- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x MAN- BMA: beta-D-mannopyranose-(1-3)-alpha-D-mannopyranose(Non-covalent)
MAN-BMA.3: 5 residues within 4Å:- Chain A: N.129, I.130, S.131
- Ligands: NAG-NAG-BMA.2, NAG-NAG-BMA.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:I.130
MAN-BMA.26: 5 residues within 4Å:- Chain B: N.129, I.130, S.131
- Ligands: NAG-NAG-BMA.25, NAG-NAG-BMA.25
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:I.130
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.4: 3 residues within 4Å:- Chain A: N.40
- Chain B: K.78, I.79
No protein-ligand interaction detected (PLIP)NAG.5: 3 residues within 4Å:- Chain A: S.127, W.128, N.129
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.127, A:S.127, A:S.127, A:N.129
NAG.7: 3 residues within 4Å:- Chain A: Y.326, N.457
- Ligands: NAG.8
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.326
- Hydrogen bonds: A:N.457
NAG.8: 1 residues within 4Å:- Ligands: NAG.7
No protein-ligand interaction detected (PLIP)NAG.9: 7 residues within 4Å:- Chain A: N.474, T.476, Q.477, Q.488, F.526, G.531
- Ligands: NAG.10
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.526
- Hydrogen bonds: A:N.474, A:Q.488
- Water bridges: A:N.474, A:G.531
NAG.10: 1 residues within 4Å:- Ligands: NAG.9
No protein-ligand interaction detected (PLIP)NAG.27: 3 residues within 4Å:- Chain A: K.78, I.79
- Chain B: N.40
No protein-ligand interaction detected (PLIP)NAG.28: 3 residues within 4Å:- Chain B: S.127, W.128, N.129
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.127, B:S.127, B:S.127, B:N.129
NAG.30: 3 residues within 4Å:- Chain B: Y.326, N.457
- Ligands: NAG.31
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:Y.326
- Hydrogen bonds: B:N.457
NAG.31: 1 residues within 4Å:- Ligands: NAG.30
No protein-ligand interaction detected (PLIP)NAG.32: 7 residues within 4Å:- Chain B: N.474, T.476, Q.477, Q.488, F.526, G.531
- Ligands: NAG.33
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.526
- Hydrogen bonds: B:N.474, B:Q.488
- Water bridges: B:N.474, B:G.531
NAG.33: 1 residues within 4Å:- Ligands: NAG.32
No protein-ligand interaction detected (PLIP)- 2 x BMA: beta-D-mannopyranose(Non-functional Binders)
- 4 x ZN: ZINC ION(Non-covalent)
ZN.11: 6 residues within 4Å:- Chain A: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.12
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.232, A:H.379, A:H.411, H2O.4
ZN.12: 5 residues within 4Å:- Chain A: D.160, H.162, D.232, H.413
- Ligands: ZN.11
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.160, A:D.232, A:H.413, H2O.4
ZN.34: 6 residues within 4Å:- Chain B: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.35
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.232, B:H.379, B:H.411, H2O.11
ZN.35: 5 residues within 4Å:- Chain B: D.160, H.162, D.232, H.413
- Ligands: ZN.34
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.160, B:D.232, B:H.413, H2O.11
- 22 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 2 residues within 4Å:- Chain A: H.384, H.411
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain A: K.59, N.62
- Chain B: K.59, N.62
- Ligands: SO4.37
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain A: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain A: K.141, S.144
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain A: R.102, F.285, I.286, E.287, H.290
Ligand excluded by PLIPSO4.18: 2 residues within 4Å:- Chain A: S.126, S.127
Ligand excluded by PLIPSO4.19: 6 residues within 4Å:- Chain A: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain A: P.534, S.535, E.536
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain A: T.412, Y.442, I.443
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain A: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain A: R.515, G.516
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain B: H.384, H.411
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain A: K.59, N.62
- Chain B: K.59, N.62
- Ligands: SO4.14
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain B: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain B: K.141, S.144
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain B: R.102, F.285, I.286, E.287, H.290
Ligand excluded by PLIPSO4.41: 2 residues within 4Å:- Chain B: S.126, S.127
Ligand excluded by PLIPSO4.42: 6 residues within 4Å:- Chain B: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain B: P.534, S.535, E.536
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain B: T.412, Y.442, I.443
Ligand excluded by PLIPSO4.45: 4 residues within 4Å:- Chain B: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain B: R.515, G.516
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, Y.F. et al., Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Nat Commun (2016)
- Release Date
- 2016-09-07
- Peptides
- Sphingomyelin phosphodiesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x MAN- BMA: beta-D-mannopyranose-(1-3)-alpha-D-mannopyranose(Non-covalent)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 2 x BMA: beta-D-mannopyranose(Non-functional Binders)
- 4 x ZN: ZINC ION(Non-covalent)
- 22 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, Y.F. et al., Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Nat Commun (2016)
- Release Date
- 2016-09-07
- Peptides
- Sphingomyelin phosphodiesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A